{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:33:36Z","timestamp":1780468416334,"version":"3.54.1"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.15444","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T15:02:49Z","timestamp":1599663769000},"page":"e2015444","source":"Crossref","is-referenced-by-count":50,"title":["Association of Immunotherapy With Survival Among Patients With Brain Metastases Whose Cancer Was Managed With Definitive Surgery of the Primary Tumor"],"prefix":"10.1001","volume":"3","author":[{"given":"Saber","family":"Amin","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Nebraska Medical Center, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Baine","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Nebraska Medical Center, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L.","family":"Meza","sequence":"additional","affiliation":[{"name":"College of Public Health, Department of Biostatistics, University of Nebraska Medical Center, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Nebraska Medical Center, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"issue":"25","key":"zoi200576r1","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1200\/JCO.2005.03.145","article-title":"Current management of brain metastases, with a focus on systemic options.","volume":"23","author":"Langer","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi200576r2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/neuonc\/nou099","article-title":"Incidence of brain metastasis at initial presentation of lung cancer.","volume":"17","author":"Villano","year":"2015","journal-title":"Neuro Oncol"},{"issue":"19","key":"zoi200576r3","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.3748\/wjg.v21.i19.5805","article-title":"Incidence and treatment of brain metastasis in patients with esophageal carcinoma.","volume":"21","author":"Feng","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"9","key":"zoi200576r4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/neuonc\/nos152","article-title":"Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.","volume":"14","author":"Davis","year":"2012","journal-title":"Neuro Oncol"},{"issue":"1","key":"zoi200576r5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases.","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"zoi200576r6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases.","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"zoi200576r7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-811161-1.00001-3","article-title":"Overview of metastatic disease of the central nervous system.","volume":"149","author":"Nolan","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"zoi200576r8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.clcc.2015.05.009","article-title":"Brain metastasis in colorectal cancer patients: survival and analysis of prognostic factors.","volume":"14","author":"Michl","year":"2015","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"zoi200576r9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1756-9966-30-10","article-title":"Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center.","volume":"30","author":"Fabi","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"zoi200576r10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/ijcp.12395","article-title":"Brain metastasis from gastrointestinal cancers: a systematic review.","volume":"68","author":"Esmaeilzadeh","year":"2014","journal-title":"Int J Clin Pract"},{"key":"zoi200576r11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fonc.2016.00049","article-title":"Systemic immunotherapy for the treatment of brain metastases.","volume":"6","author":"Cohen","year":"2016","journal-title":"Front Oncol"},{"issue":"2","key":"zoi200576r12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi200576r13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","article-title":"A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.","volume":"31","author":"Soffietti","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"zoi200576r14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11910-018-0877-8","article-title":"Management of brain metastases in the new era of checkpoint inhibition.","volume":"18","author":"Lauko","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"zoi200576r15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.12703\/P","article-title":"Brain metastasis and treatment.","volume":"6","author":"Ahluwalia","year":"2014","journal-title":"F1000Prime Rep"},{"issue":"5","key":"zoi200576r16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/neuonc\/nov023","article-title":"Unsanctifying the sanctuary: challenges and opportunities with brain metastases.","volume":"17","author":"Puhalla","year":"2015","journal-title":"Neuro Oncol"},{"issue":"1","key":"zoi200576r17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/annonc\/mdu486","article-title":"Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.","volume":"26","author":"Krop","year":"2015","journal-title":"Ann Oncol"},{"key":"zoi200576r18","first-page":"1789","article-title":"Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients.","volume":"6","author":"Fan","year":"2013","journal-title":"Onco Targets Ther"},{"issue":"5","key":"zoi200576r19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3171\/2012.2.JNS111353","article-title":"The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery.","volume":"116","author":"Cochran","year":"2012","journal-title":"J Neurosurg"},{"issue":"2","key":"zoi200576r20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/2012.5.JNS111929","article-title":"Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.","volume":"117","author":"Knisely","year":"2012","journal-title":"J Neurosurg"},{"key":"zoi200576r21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14694\/EdBook_AM.2015.35.67","article-title":"Targeted and immunotherapeutic approaches in brain metastases.","author":"Ahluwalia","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"7","key":"zoi200576r22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.","volume":"17","author":"Goldberg","year":"2016","journal-title":"Lancet Oncol"},{"issue":"8","key":"zoi200576r23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain.","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi200576r24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijrobp.2015.01.004","article-title":"Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.","volume":"92","author":"Kiess","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"zoi200576r25","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1283461","article-title":"Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab.","volume":"6","author":"Skrepnik","year":"2017","journal-title":"Oncoimmunology"},{"issue":"19","key":"zoi200576r26","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1002\/cncr.v122.19","article-title":"Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.","volume":"122","author":"Qian","year":"2016","journal-title":"Cancer"},{"issue":"5","key":"zoi200576r27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"issue":"26","key":"zoi200576r28","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.","volume":"364","author":"Robert","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi200576r29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-018-2880-y","article-title":"Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity.","volume":"139","author":"Diao","year":"2018","journal-title":"J Neurooncol"},{"issue":"1","key":"zoi200576r30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cam4.2015.4.issue-1","article-title":"Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery.","volume":"4","author":"Tazi","year":"2015","journal-title":"Cancer Med"},{"issue":"6","key":"zoi200576r31","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cam4.2013.2.issue-6","article-title":"Ipilimumab and radiation therapy for melanoma brain metastases.","volume":"2","author":"Silk","year":"2013","journal-title":"Cancer Med"},{"issue":"9","key":"zoi200576r32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1470-2045(12)70324-8","article-title":"Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.","volume":"13","author":"Di Giacomo","year":"2012","journal-title":"Lancet Oncol"},{"issue":"6","key":"zoi200576r33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/CMR.0b013e32834d3d88","article-title":"Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.","volume":"21","author":"Weber","year":"2011","journal-title":"Melanoma Res"},{"issue":"2","key":"zoi200576r34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijrobp.2015.01.004","article-title":"Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.","volume":"92","author":"Kiess","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"zoi200576r35","doi-asserted-by":"publisher","first-page":"9076","DOI":"10.1200\/jco.2014.32.15_suppl.9076","article-title":"Outcome with stereotactic radiosurgery (SRS) and ipilimumab (ipi) for malignant melanoma brain metastases (mets).","volume":"32","author":"Shoukat","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"zoi200576r36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.adro.2017.07.003","article-title":"Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents.","volume":"2","author":"Acharya","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"zoi200576r37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/COC.0000000000000509","article-title":"Concurrent radiosurgery and immune checkpoint inhibition: Improving regional intracranial control for patients with metastatic melanoma.","volume":"42","author":"Murphy","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"zoi200576r38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2013.09.018","article-title":"Abscopal effects of radiation therapy: a clinical review for the radiobiologist.","volume":"356","author":"Siva","year":"2015","journal-title":"Cancer Lett"},{"issue":"7","key":"zoi200576r39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"zoi200576r40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fonc.2014.00325","article-title":"Combinations of immunotherapy and radiation in cancer therapy.","volume":"4","author":"Vatner","year":"2014","journal-title":"Front Oncol"},{"key":"zoi200576r41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases\u2014elimination, equilibrium and escape.","volume":"27","author":"Mittal","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"zoi200576r42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.coi.2008.05.008","article-title":"Immunogenic anti-cancer chemotherapy as an emerging concept.","volume":"20","author":"Haynes","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"zoi200576r43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10555-011-9283-2","article-title":"How to improve the immunogenicity of chemotherapy and radiotherapy.","volume":"30","author":"Ma","year":"2011","journal-title":"Cancer Metastasis Rev"},{"issue":"7683","key":"zoi200576r44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature24673","article-title":"Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.","volume":"552","author":"Germano","year":"2017","journal-title":"Nature"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2770284\/amin_2020_oi_200576_1602712474.73054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T22:01:32Z","timestamp":1602712892000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2770284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.15444","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]}}}